Online Exclusive Article

Malglycemia and Cancer: Introduction to a Conceptual Model

Marilyn J. Hammer Joachim G. Voss
nursing research, clinical nursing research
ONF 2012, 39(3), E275-E287. DOI: 10.1188/12.ONF.E275-E287

Purpose/Objectives: To introduce a conceptual model detailing the physiologic contributions of malglycemia to cancer formation and increased morbidity and mortality.

Data Sources: A literature search was conducted using the PubMed, CINAHL®, and Cochrane databases, as well as Surveillance, Epidemiology and End Results (SEER) cancer statistics.

Data Synthesis: Multiple complex factors are associated with malignancy formation, proliferation, and outcomes for each individual. The authors present a model, termed the Malglycemia Orbit Model, that is analogous to an atom, centered on a core of individual factors, and surrounded by "orbits" containing cancer and related factors. Highlighted in this model is the role of malglycemia.

Conclusions: Cancer formation and sequelae involve numerous multifaceted factors. One factor not well described or understood within the context of malignancies is glycemic status, most notably how malglycemia impacts cancer formation and risks for adverse outcomes. The atomic-structured malglycemia model describes this process.

Implications for Nursing: Among the many uncontrollable factors that contribute to cancer formation and adverse outcomes, malglycemia is one that is modifiable. Nurses are in a prime position to conduct research to enhance understanding and ultimately improve protocols for better glycemic control and, in effect, better outcomes for individuals with cancer.

Jump to a section

    References

    Albert, S., Serova, M., Dreyer, C., Sablin, M. P., Faivre, S., & Raymond, E. (2010). New inhibitors of the mammalian target of rapamycin signaling pathway for cancer. Expert Opinion on Investigational Drugs, 19, 919-930. doi:10.1517/13543784.2010.499121
    American Diabetes Association. (2011). Tight diabetes control. Living with diabetes. Retrieved from http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/tight-diabetes-control.html
    American Nuclear Society. (2011). The atom: Structure of the atom. Retrieved from http://www.aboutnuclear.org/view.cgi?fC=The_Atom,Structure_of_the_Atom
    Anand, P., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., … Aggarwal, B. B. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research, 25, 2097-2116. doi:10.1007/s11095-008-9661-9
    Anatoliotaki, M., Valatas, V., Mantadakis, E., Apostolakou, H., Mavroudis, D., Georgoulias, V., … Samonis, G. (2004). Bloodstream infections in patients with solid tumors: Associated factors, microbial spectrum, and outcome. Infection, 32, 65-71. doi:10.1007/s15010-004-3049-5
    Armaiz-Pena, G. N., Lutgendorf, S. K., Cole, S. W., & Sood, A. K. (2009). Neuroendocrine modulation of cancer progression. Brain, Behavior, and Immunity, 23, 10-15. doi:10.1016/j.bbi.2008.06.007
    Barnes, P. D., & Marr, K. A. (2007). Risks, diagnosis, and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. British Journal of Haematology, 139, 519-531. doi:10.1111/j.1365-2141.2007.06812.x
    Barone, B. B., Yeh, H. C., Snyder, C. F., Peairs, K. S., Stein, K. B., Derr, R. L., … Brancati, F. L. (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA, 300, 2754-2764. doi:10.1001/jama.2008.824
    Baylin, S. B. (2008). Epigenetics and cancer. In J. Mendelsohn, P. M. Howley, M. A. Israel, J. W. Gray, & C. B. Thompson (Eds.), The molecular basis of cancer (3rd ed., pp. 57-65). Philadelphia, PA: Saunders Elsevier.
    Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., … Thun, M. J. (2010). Body-mass index and mortality among 1.46 million White adults. New England Journal of Medicine, 363, 2211-2219. doi:10.1056/NEJMoa1000367
    Bertz, H., Auner, H. W., Weissinger, F., Salwender, H. J., Einsele, H., Egerer, G., … Maschmeyer, G. (2003). Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology, 82(Suppl. 2), S167-S174. doi:10.1007/s00277-003-0771-5
    Braithwaite, S. S. (2008). Inpatient insulin therapy. Current Opinion in Endocrinology, Diabetes, and Obesity, 15, 159-166. doi:10.1097/MED.0b013e3282f827e7
    Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54, 1615-1625.
    Burke, K. E., & Wei, H. (2009). Synergistic damage by UVA radiation and pollutants. Toxicology and Industrial Health, 25(4-5), 219-224. doi:10.1177/0748233709106067
    Butler, S. O., Btaiche, I. F., & Alaniz, C. (2005). Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy, 25, 963-976.
    Campisi, J. (2011). Cellular senescence: Putting the paradoxes in perspective. Current Opinion in Genetics and Development, 21(1), 107-112. doi:10.1016/j.gde.2010.10.005
    Campisi, J., & d'Adda di Fagagna, F. (2007). Cellular senescence: When bad things happen to good cells. Nature Reviews. Molecular Cell Biology, 8, 729-740. doi:10.1038/nrm2233
    Campisi, J., & Yaswen, P. (2009). Aging and cancer cell biology. Aging Cell, 8, 221-225. doi:10.1111/j.1474-9726.2009.00475.x
    Coppe, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., … Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology, 6, 2853-2868. doi:10.1371/journal.pbio.0060301
    Costanzo, E. S., Sood, A. K., & Lutgendorf, S. K. (2011). Biobehavioral influences on cancer progression. Immunology and Allergy Clinics of North America, 31, 109-132. doi:10.1016/j.iac.2010.09.001
    Deng, D., Liu, Z., & Du, Y. (2010). Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Advances in Genetics, 71, 125-176. doi:10.1016/B978-0-12-380864-6.00005-5
    Depke, M., Fusch, G., Domanska, G., Geffers, R., Volker, U., Schuett, C., & Kiank, C. (2008). Hypermetabolic syndrome as a consequence of repeated psychological stress in mice. Endocrinology, 149, 2714-2723.
    Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004). The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 21, 137-148. doi:10.1016/j.immuni.2004.07.017
    El Mjiyad, N., Caro-Maldonado, A., Ramirez-Peinado, S., & Munoz-Pinedo, C. (2011). Sugar-free approaches to cancer cell killing. Oncogene, 30, 253-264. doi:10.1038/onc.2010.466
    Esfahani, A., Wong, J. M., Mirrahimi, A., Srichaikul, K., Jenkins, D. J., & Kendall, C. W. (2009). The glycemic index: Physiological significance. Journal of the American College of Nutrition, 28(Suppl.), 439S-445S.
    Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., … Giugliano, D. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation, 106, 2067-2072.
    Freund, A., Orjalo, A. V., Desprez, P. Y., & Campisi, J. (2010). Inflammatory networks during cellular senescence: Causes and consequences. Trends in Molecular Medicine, 16, 238-246. doi:10.1016/j.molmed.2010.03.003
    Fuji, S., Kim, S. W., Mori, S., Fukuda, T., Kamiya, S., Yamasaki, S., … Takaue, Y. (2007). Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation, 84, 814-820. doi:10.1097/01.tp.0000296482.50994.1c
    Fulop, T., Kotb, R., Fortin, C. F., Pawelec, G., de Angelis, F., & Larbi, A. (2010). Potential role of immunosenescence in cancer development. Annals of the New York Academy of Sciences, 1197, 158-165. doi:10.1111/j.1749-6632.2009.05370.x
    Gearhart, M. M., & Parbhoo, S. K. (2006). Hyperglycemia in the critically ill patient. AACN Clinical Issues, 17, 50-55.
    Germenis, A. E., & Karanikas, V. (2007). Immunoepigenetics: The unseen side of cancer immunoediting. Immunology and Cell Biology, 85, 55-59. doi:10.1038/sj.icb.7100006
    Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107, 1058-1070. doi:10.1161/CIRCRESAHA.110.223545
    Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., … Yee, D. (2010). Diabetes and cancer: A consensus report. Diabetes Care, 33, 1674-1685. doi:10.2337/dc10-0666
    Giugliano, D., Ceriello, A., & Esposito, K. (2008). Glucose metabolism and hyperglycemia. American Journal of Clinical Nutrition, 87, 217S-222S.
    Godbout, J. P., & Glaser, R. (2006). Stress-induced immune dysregulation: Implications for wound healing, infectious disease, and cancer. Journal of Neuroimmune Pharmacology, 1, 421-427. doi:10.1007/s11481-006-9036-0
    Gonzalez, C. A., & Riboli, E. (2010). Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. European Journal of Cancer, 46, 2555-2562. doi:10.1016/j.ejca.2010.07.025
    Green, K., Brand, M. D., & Murphy, M. P. (2004). Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes, 53(Suppl. 1), S110-S118.
    Grimes, A., & Chandra, S. B. (2009). Significance of cellular senescence in aging and cancer. Cancer Research and Treatment, 41(4), 187-195. doi:10.4143/crt.2009.41.4.187
    Hait, W. N., Rubin, E., & Bertino, J. R. (2008). Cancer therapeutics. In P. M. Howley, J. Mendelsohn, M. A. Israel, J. W. Gray, & C. B. Thompson (Eds.), The molecular basis of cancer (3rd ed., pp. 757). Philadelphia, PA: Saunders Elsevier.
    Hamalainen, S., Kuittinen, T., Matinlauri, I., Nousiainen, T., Koivula, I., & Jantunen, E. (2009). Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors, and outcome. Scandinavian Journal of Infectious Diseases, 41, 14-20. doi:10.1080/00365540802454706
    Hammer, M. J., Casper, C., Gooley, T. A., O'Donnell, P. V., Boeckh, M., & Hirsch, I. B. (2009). The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biology of Blood and Marrow Transplantation, 15, 344-351. doi:10.1016/j.bbmt.2008.12.488
    Hammer, M. J., Motzer, S. A., Voss, J. G., & Berry, D. L. (2010). Glycemic control among older adult hematopoietic cell transplant recipients. Journal of Gerontological Nursing, 36(2), 40-50. doi:10.3928/00989134-20091207-00989199
    Hirsch, I. B., & Brownlee, M. (2005). Should minimal blood glucose variability become the gold standard of glycemic control? Journal of Diabetes and Its Complications, 19(3), 178-181. doi:10.1016/j.jdiacomp.2004.10.001
    Hochedlinger, K., & Plath, K. (2009). Epigenetic reprogramming and induced pluripotency. Development, 136, 509-523. doi:10.1242/dev.020867
    Howlader, N., Noone, A. M., Krapcho, M., Neyman, N., Aminou, R., & Waldron, W. (Eds). (2011). SEER cancer statistics review, 1975-2008. Retrieved from http://www.seer.cancer.gov/statfacts/html/all.html
    Hursting, S. D., & Berger, N. A. (2010). Energy balance, host-related factors, and cancer progression. Journal of Clinical Oncology, 28, 4058-4065. doi:10.1200/JCO.2010.27.9935
    Janeway, C. A., Jr., & Medzhitov, R. (2002). Innate immune recognition. Annual Review of Immunology, 20, 197-216. doi:10.1146/annurev.immunol.20.083001.084359
    Jenkins, D. J., Kendall, C. W., Augustin, L. S., Franceschi, S., Hamidi, M., Marchie, A., … Axelsen, M. (2002). Glycemic index: Overview of implications in health and disease. American Journal of Clinical Nutrition, 76, 266S-273S.
    Kalsbeek, A., Bruinstroop, E., Yi, C. X., Klieverik, L. P., La Fleur, S. E., & Fliers, E. (2010). Hypothalamic control of energy metabolism via the autonomic nervous system. Annals of the New York Academy of Sciences, 1212, 114-129. doi:10.1111/j.1749-6632.2010.05800.x
    Kant, P., & Hull, M. A. (2011). Excess body weight and obesity—The link with gastrointestinal and hepatobiliary cancer. Nature Reviews. Gastroenterology and Hepatology, 8, 8. doi:10.1038/nrgastro.2011.23
    Katz, A. (2007). Modulation of glucose transport in skeletal muscle by reactive oxygen species. Journal of Applied Physiology, 102, 1671-1676. doi:10.1152/japplphysiol.01066.2006
    Kawamori, D., Welters, H. J., & Kulkarni, R. N. (2010). Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction. Advances in Experimental Medicine and Biology, 654, 421-445. doi:10.1007/978-90-481-3271-3_18
    Klaunig, J. E., & Kamendulis, L. M. (2004). The role of oxidative stress in carcinogenesis. Annual Review of Pharmacology and Toxicology, 44, 239-267. doi:10.1146/annurev.pharmtox.44.101802.121851
    Koul, A., & Arora, N. (2010). Celecoxib mitigates cigarette smoke induced oxidative stress in mice. Indian Journal of Biochemistry and Biophysics, 47, 285-291.
    Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010). The essence of senescence. Genes and Development, 24, 2463-2479. doi:10.1101/gad.1971610
    Kulis, M., & Esteller, M. (2010). DNA methylation and cancer. Advances in Genetics, 70, 27-56. doi:10.1016/B978-0-12-380866-0.60002-2
    Lee, Y. J., Doliny, P., Gomez-Fernandez, C., Powell, J., Reis, I., & Hurley, J. (2004). Docetaxel and cisplatin as primary chemotherapy for treatment of locally advanced breast cancers. Clinical Breast Cancer, 5, 371-376.
    Leonidou, L., Mouzaki, A., Michalaki, M., DeLastic, A. L., Kyriazopoulou, V., Bassaris, H. P., & Gogos, C. A. (2007). Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. Journal of Infection, 55, 340-346. doi:10.1016/j.jinf.2007.05.177
    Livesey, G., Taylor, R., Hulshof, T., & Howlett, J. (2008). Glycemic response and health—A systematic review and meta-analysis: Relations between dietary glycemic properties and health outcomes. American Journal of Clinical Nutrition, 87, 258S-268S.
    Ljungman, P. (2007). Risk assessment in haematopoietic stem cell transplantation: Viral status. Best practice and research. Clinical Haematology, 20, 209-217. doi:10.1016/j.beha.2006.09.003
    Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454, 436-444. doi:10.1038/nature07205
    Marek, C. B., Peralta, R. M., Itinose, A. M., & Bracht, A. (2011). Influence of tamoxifen on gluconeogenesis and glycolysis in the perfused rat liver. Chemico-Biological Interactions, 4, 4. doi:10.1016/j.cbi.2011.04.010
    Martin-Salces, M., de Paz, R., Canales, M. A., Mesejo, A., & Hernandez-Navarro, F. (2008). Nutritional recommendations in hematopoietic stem cell transplantation. Nutrition, 24(7-8), 769-775. doi:10.1016/j.nut.2008.02.021
    Massa, M. L., Gagliardino, J. J., & Francini, F. (2011). Liver glucokinase: An overview on the regulatory mechanisms of its activity. IUBMB Life, 63(1), 1-6. doi:10.1002/iub.1411
    Mathers, J. C., Strathdee, G., & Relton, C. L. (2010). Induction of epigenetic alterations by dietary and other environmental factors. Advances in Genetics, 71, 3-39. doi:10.1016/B978-0-12-380864-6.00001-8
    Mazali, F. C., Lalli, C. A., Alves-Filho, G., & Mazzali, M. (2008). Posttransplant diabetes mellitus: Incidence and risk factors. Transplantation Proceedings, 40, 764-766. doi:10.1016/j.transproceed.2008.03.018
    McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001). Stress-induced hyperglycemia. Critical Care Clinics, 17, 107-124.
    Mendelsohn, J., Howley, P. M., Israel, M. A., Gray, J. W., & Thompson, C. B. (Eds.). (2008). The molecular basis of cancer (3rd ed.). Philadelphia, PA: Saunders Elsevier.
    Moeller, D. W., & Sun, L. S. (2010). Chemical and radioactive carcinogens in cigarettes: Associated health impacts and responses of the tobacco industry, U. S. Congress, and federal regulatory agencies. Health Physics, 99, 674-679. doi:10.1097/HP.0b013e3181df5439
    Moien-Afshari, F., Ghosh, S., Khazaei, M., Kieffer, T. J., Brownsey, R. W., & Laher, I. (2008). Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice. Diabetologia, 51, 1327-1337. doi:10.1007/s00125-008-0996-x
    Monnier, L., Colette, C., & Owens, D. R. (2008). Glycemic variability: The third component of the dysglycemia in diabetes. Is it important? How to measure it? Journal of Diabetes Science and Technology, 2, 1094-1100.
    National Institute of Diabetes and Digestive and Kidney Diseases. (2011). National diabetes statistics, 2011. Retrieved from http://diabetes.niddk.nih.gov/DM/PUBS/statistics/#i_people
    Nichols, W. G. (2003). Management of infectious complications in the hematopoietic stem cell transplant recipient. Journal of Intensive Care Medicine, 18, 295-312. doi:10.1177/0885066603258009
    Nikolajczyk, B. S., Jagannathan-Bogdan, M., Shin, H., & Gyurko, R. (2011). State of the union between metabolism and the immune system in type 2 diabetes. Genes and Immunity, 10, 10. doi:10.1038/gene.2011.14
    Pal, S. K., & Hurria, A. (2010). Impact of age, sex, and comorbidity on cancer therapy and disease progression. Journal of Clinical Oncology, 28, 4086-4093. doi:10.1200/JCO.2009.27.0579
    Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
    Pasarica, M., & Dhurandhar, N. V. (2007). Infectobesity: Obesity of infectious origin. Advances in Food and Nutrition Research, 52, 61-102. doi:10.1016/S1043-4526(06)52002-9
    Pawelec, G., Derhovanessian, E., & Larbi, A. (2010). Immunosenescence and cancer. Critical Reviews in Oncology/Hematology, 75, 165-172. doi:10.1016/j.critrevonc.2010.06.012
    Pickup, J. C. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27, 813-823.
    Pinto, B. M., & Trunzo, J. J. (2005). Health behaviors during and after a cancer diagnosis. Cancer, 104(11, Suppl.), 2614-2623.
    Poutsiaka, D. D., Price, L. L., Ucuzian, A., Chan, G. W., Miller, K. B., & Snydman, D. R. (2007). Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplantation, 40, 63-70. doi:10.1038/sj.bmt.1705690
    Ramos-Cebrian, M., Torregrosa, J. V., Gutierrez-Dalmau, A., Oppenheimer, F., & Campistol, J. M. (2007). Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. Transplantation Proceedings, 39, 2251-2253. doi:10.1016/j.transproceed.2007.06.035
    Reiman, J. M., Kmieciak, M., Manjili, M. H., & Knutson, K. L. (2007). Tumor immunoediting and immunosculpting pathways to cancer progression. Seminars in Cancer Biology, 17, 275-287. doi:10.1016/j.semcancer.2007.06.009
    Rodier, F., & Campisi, J. (2011). Four faces of cellular senescence. Journal of Cell Biology, 192, 547-556. doi:10.1083/jcb.201009094
    Roumen, C., Blaak, E. E., & Corpeleijn, E. (2009). Lifestyle intervention for prevention of diabetes: Determinants of success for future implementation. Nutrition Reviews, 67(3), 132-146. doi:10.1111/j.1753-4887.2009.00181.x
    Rueth, N. M., Murray, S. E., Huddleston, S. J., Abbott, A. M., Greeno, E. W., Kirstein, M. N., & Tuttle, T. M. (2011). Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: Oxaliplatin versus mitomycin C. Annals of Surgical Oncology, 18, 174-180. doi:10.1245/s10434-010-1210-1
    Sato, M., Yao, V. J., Arap, W., & Pasqualini, R. (2010). GRP78 signaling hub a receptor for targeted tumor therapy. Advances in Genetics, 69, 97-114. doi:10.1016/S0065-2660(10)69006-2
    Schottenfeld, D., & Beebe-Dimmer, J. (2006). Alleviating the burden of cancer: A perspective on advances, challenges, and future directions. Cancer Epidemiology, Biomarkers and Prevention, 15, 2049-2055. doi:10.1158/1055-9965.EPI-06-0603
    Serna, D. S., Lee, S. J., Zhang, M. J., Baker, S., Eapen, M., Horowitz, M. M., … Loberiza, F. R., Jr. (2003). Trends in survival rates after allogeneic hematopoietic stem cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. Journal of Clinical Oncology, 21, 3754-3760. doi:10.1200/JCO.2003.03.133
    Sheean, P., & Braunschweig, C. (2006). The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients. Journal of Parenteral and Enteral Nutrition, 30, 345-350.
    Smiley, D., & Umpierrez, G. E. (2010). Management of hyperglycemia in hospitalized patients. Annals of the New York Academy of Sciences, 1212, 1-11. doi:10.1111/j.1749-6632.2010.05805.x
    Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006). Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Advances in Immunology, 90, 1-50. doi:10.1016/S0065-2776(06) 90001-7
    Stookey, J. D., Pieper, C. F., & Cohen, H. J. (2004). Hypertonic hyperglycemia progresses to diabetes faster than normotonic hyperglycemia. European Journal of Epidemiology, 19, 935-944.
    Sutandyo, N. (2010). Nutritional carcinogenesis. Acta Medica Indonesia, 42, 36-42.
    Trelinska, J., Fendler, W., Szadkowska, A., Czerwoniuk, D., Mianowska, B., Wegner, O., & Mlynarski, W. (2011). Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy. Leukemia and Lymphoma, 17, 17.
    Turina, M., Christ-Crain, M., & Polk, H. C., Jr. (2006). Diabetes and hyperglycemia: Strict glycemic control. Critical Care Medicine, 34(9, Suppl.), S291-S300. doi:10.1097/01.CCM.0000231887.84751.04
    van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., … Bouillon, R. (2001). Intensive insulin therapy in the critically ill patients. New England Journal of Medicine, 345, 1359-1367. doi:10.1056/NEJMoa011300
    Velayutham, M., Hemann, C., & Zweier, J. L. (2011). Removal of H(2)O(2) and generation of superoxide radical: Role of cytochrome c and NADH. Free Radical Biology and Medicine, 51, 160-170. doi:10.1016/j.freeradbiomed.2011.04.007
    Vischer, U. M., Bauduceau, B., Bourdel-Marchasson, I., Blickle, J. F., Constans, T., Fagot-Campagna, A., … Alfediam, S. (2009). A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes and Metabolism, 35, 168-177. doi:10.1016/j.diabet.2009.02.003
    Watanabe, Y., & Maekawa, M. (2010). Methylation of DNA in cancer. Advances in Clinical Chemistry, 52, 145-167.
    Willi, S. M., Kennedy, A., Wallace, P., Ganaway, E., Rogers, N. L., & Garvey, W. T. (2002). Troglitazone antagonizes metabolic effects of glucocorticoids in humans: Effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes, 51, 2895-2902.
    Wilson, A. G. (2008). Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. Journal of Periodontology, 79(8, Suppl.), 1514-1519. doi:10.1902/jop.2008.080172
    Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., & Loeb, L. A. (2004). Environmental and chemical carcinogenesis. Seminars in Cancer Biology, 14, 473-486. doi:10.1016/j.semcancer.2004.06.010
    Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. (2001). Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. Journal of Clinical Oncology, 19, 1147-1151.
    Yu, T., Jhun, B. S., & Yoon, Y. (2011). High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission. Antioxidants and Redox Signaling, 14, 425-437. doi:10.1089/ars.2010.3284
    Ziech, D., Franco, R., Georgakilas, A. G., Georgakila, S., Malamou-Mitsi, V., Schoneveld, O., … Panayiotidis, M. I. (2010). The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chemico-Biological Interactions, 188, 334-339. doi:10.1016/j.cbi.2010.07.010
    Zinn, A. R. (2010). Unconventional wisdom about the obesity epidemic. American Journal of the Medical Sciences, 340, 481-491. doi:10.1097/MAJ.0b013e3181ccb980